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1. Introduction 
Using xenograft from transgenic (Tg) pigs is a promising approach to lessen the organ 
shortage for transplantation. Transgenesis such as CD55 or CD46, and CD59 as well as alpha 
1, 3-galactosyl transferase gene knockouts shall avoid rejections. Indeed, grafts obtained 
either from hDAF (CD55) Tg pigs or from alpha 1, 3-galactosyl transferase gene knock-out 
pigs, all can overcome hyperacute rejection in xenotransplantation since porcine hearts 
could survive heterotopically in non-human primates more than 6 months (Kuwaki et al., 
2005; Tai et al., 2007;). Obstacles are still remaining however, as early inflammation, acute 
humoral and acute cellular xeno-rejections and thrombotic microangiopathy are the 
following problems yet to tackle (Tai et al., 2007).  
The early inflammation involves up-regulation of pro-inflammatory mediators in the graft 
and occurs before the T cell responses after engraftment. It is an innate response of NK cells 
to tissue injury and independent of the adaptive immune system. The major 
histocompatibility complex (MHC) molecules in human, including human leukocyte antigen 
(HLA) E, G, and class I molecules, in theory, can inhibit human NK cells xeno-rejection 
(Sasaki et al., 1999). This is proven by generating the HLA-E/human beta 2-microglobulin 
Tg pigs that can express transgenes consistently in peripheral blood mononuclear cells and 
on endothelial cells of organs, including heart and kidney, and these transgenes can provide 
partial protection against human NK rejections (Weiss et al., 2009). 
In acute cellular rejection, T-cells cytotoxicity is responsible for the major cell-mediated 
rejections. In human allotransplantation, the donor-recipient match of HLA-II improves 
graft survivals, especially in kidney transplantation (Sheldon et al., 1999; McKenna et al., 
2000). Yet, the roles of HLA-II to attenuate acute cell-mediated xeno-rejections remain 
uncertain. We have successfully generated HLA-DP, DQ and DR Tg pigs and showed that 
human-to-pig xenogenic cellular responses could be significantly depressed by expressing 
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HLA-DP, -DQ or -DR exogenes on porcine cells (Tu et al., 2000a, 1999, 2000b, and 2001; 
Wang et al., 2004; Tu et al., 2003). The purpose of this review is an attempt to elucidate the 
functions of HLA-II in xenotransplantation. 
2. The expression of DP or DQ exogenes in HLA-DP or DQ transgenic pigs 
reduced human-to-pig cellular responses 
In allotransplantation, HLA-II matching could improve graft survivals, especially in kidney 
transplantation (Sheldon et al., 1999; McKenna et al., 2000), possibly due to better donor 
lymphocyte survival in recipients, so-called microchimerism (Starzl et al., 1992). However, 
the roles of HLA-II in porcine xenograft remain to be elucidated. In acute cell-mediated 
xeno-rejections, both direct and indirect pathways in human T-cell rejections are involving. 
The direct pathway, presumably the dominant one, engages in the early alloimmune 
response initiated by direct contact of host T-cells with allo-HLA molecules. Initially, human 
T cells recognize intact xeno-swine leukocyte antigens (SLA) on the surface of the antigen 
presenting cells (APC) or endothelial cells (EC) of transplanted pig organs. Then, human T 
cells identify  xeno-SLA molecules bound xeno-peptide as being equivalent in shape to self-
HLA bound foreign peptide and, hence, treat the xeno-tissue as foreign. In the proposed 
indirect pathway, human T cells recognize processed xeno-antigens presented as peptides 
by human APCs. 
The roles of the HLA-II antigen in iso-, allo-, and xenotransplantation have also been 
studied in HLA-DQ and HLA-DP transgenic mice (Tsuji et al., 1994). The HLA-DP and DQ 
transgenic pigs were further produced through the technique of microinjection. Genomic 
DNA clones, including HLA-DP (including both A1 and B1 sequences) (Tu et al., 1999), and 
HLA-DQA1 and HLA-DQB1 (Tu et al., 2000) were transferred into pronucleus of porcine 
fresh fertilized eggs by microinjection. The successful integration of both HLA-DP and 
HLA-DQ transgenes were proven by polymerase chain reaction (PCR), Southern blot (Tu et 
al., 1999 and Tu et al., 2000, respectively), and FISH (Wang et al., 2004). The expression was 
also revealed by reverse transcriptase-PCR (RT-PCR) and by flow cytometry in HLA-DP (Tu 
et al., 1999 and 1998; Lee et al., 2000 and 2002) and HLA-DQ (Tu et al. 2003) transgenesis. To 
elucidate the function of HLA-DP and DQ antigens, the proliferation of human peripheral 
blood mononuclear cells (PBMC) to porcine xeno-antigen could be attenuated by primed or 
direct xenogenic mixed lymphocyte culture (MLC) tests. 
The PBMC of the HLA-DPw0401 transgenic (Tg) pigs induced a stronger cellular reaction 
to HLA-DPw0401+-primed lymphocyte test reagents than their non-transgenic (NTg) 
littermates. In direct xenogenic mixed lymphocyte culture (MLC) tests with responders 
from HLA-DPw0401+ humans, the PBMCs from the HLA-DPw0401 Tg pigs, as compared 
with those from the NTg littermates, induced low xenogenic cellular responses to human 
PBMCs (Figure 1). Furthermore, after 7 days of stimulation, the human responders 
(PBMC) without the HLA-DQw0601 allele displayed stimulating index (SI) of 1.37 (+ 
0.53), 1.85 (+ 0.19), and 1.76 (+ 0.14) upon stimulation by PBMC from NTg littermates, 
wild pigs (WP), and third-party human (H) (HLADQ0601+) respectively. Human PBMC 
responders bearing the HLA DQw0601 allele showed SI of 1.35 (+ 0.12), 1.42 (+ 0.09), and 
1.10 (+ 0.16) upon stimulated by PBMC from NTg, WP, and H (HLADQ0601-) controls, 
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respectively (p < 0.05 for Tg versus WP, and Tg versus NTg). After 3 days of stimulation, 
the human PBMC responder without the human DQw0601 allele produced a higher level 
of INF-gamma when the stimulators came from the PBMC of WP, compared to Tg pigs 
(WP versus Tg: 55 + 3.75 versus 24 + 7.92 pg/mL). A similar trend was observed when the 
responders (PBMC) were obtained from the human DQw0601+ genotype (WP versus Tg: 
153 + 21.2 versus 69 + 0 pg/mL). (Figure 2) 
 
 
 
 
Fig. 1. Stimulating indexes (SI) of direct xenogenic mixed lymphocyte culture (MLC) test 
with responder of HLA-DPw4+ human lymphocytes. In direct xenogenic MLC tests with 
responders from HLA-DPw0401+ humans, the PBMCs from the HLA-DPw0401 transgenic 
(Tg) pigs, as compared with those from the non-transgenic (NTg) pigs, induced a lower 
degree of xenogenic cellular responses to human PBMCs. (n=4). 
The cellular proliferation of human PBMC under stimulation by porcine PBMC was reduced 
in the presence of HLA-DQ molecules expressed on the porcine cells, as compared to that in 
the presence of the NTg littermate control. The human-to-porcine xenogenic Th1 response, 
as represented by the production of INF-gamma, was also attenuated by stimulation with 
HLA-DQ transgenic pig cells (Lee et al., 2003). These evidences were demonstrated in 
human PBMCs with or without the HLADQw0601 allele. The studies on the HLA-DPw0401 
and DQw0601 transgenic pigs supported the concept that increasing the similarity of MHC 
class II determinants between HLA-II Tg pigs and human beings shall reduce the xenogenic 
cellular responses. 
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Fig. 2. Stimulating indices (SI) (A1 and A2) and TH1 response (INF  production) (B1 and B2) 
of direct xenogenic mixed lymphocyte culture (MLC) tests with matched or mismatched 
responders of HLA DQw0601(+ or -) human PBMCs. A1 and A2: the cellular proliferation of 
human PBMC under stimulation by porcine PBMC could be reduced in the presence of HLA-
DQ molecules expressed on the porcine cells, as compared to that in the presence of the NTg 
littermate control. B1 and B2: the human-to-porcine xenogenic Th1 response, as represented by 
the production of INF-gamma, was also attenuated by stimulation with HLA-DQ transgenic 
pig cells. Tg: HLA-DQ transgenic pig; NTg: non-transgenic littermate; WP: wild pigs; and each 
group n=3. * p < 0.05 as compared to Tg; # using the cpm of Tg as referent (SI=1). 
3. The expression of DR exogenes in HLA-DR transgenic pigs enhanced 
cyclosporine effect 
The integration of HLA-DR15+ transgenes in transgenic pigs (Tu et al., 2001) was directly 
revealed by FISH which has localized both DRA1 and DRB1 transgenes on pig chromosome 
13 near the centromere (unpublished data). The expression of transgenes has been 
confirmed by flow cytometry and the immunohistochemical stain. Results (unpublished 
data) have also shown that about 39.2% of porcine peripheral blood mononuclear cells and 
the endothelial cells on the blood vessel of transgenic pig successfully expressed HLA-DR 
antigens.  
Proteomic approach (Huang et al., 2006) revealed that the HLA-DR15+ transgenic pigs could 
express more proteins including triosephosphate isomerase, cyclophilin B (CyPB), 
proteaseme and RhoA than their non-transgenic littermates. It is of great interest to 
elucidate the association of HLA-DR with CyPB on transgenic pigs especially in 
xenotransplantation. Triosephosphate isomerase can stimulate lymphocyte proliferation 
www.intechopen.com
 
Function Measurements of HLA-II Transgenic Pigs for Xenotransplantation 
 
59 
(Richter et al., 1993) and its minor structural change corresponds to substantially enhanced 
stimulation of a CD4+ tumor-infiltrating lymphocyte line (Sundberg et al., 2002). The 
proteasome is a multicatalytic complex of proteases involved in T-lymphocyte proliferation 
and activation and plays an important role in cell–cell interaction during T-lymphocyte 
activation (Kanaan et al., 2001). The GTP-binding protein RhoA is a member of the Ras 
GTPase superfamily and has been reported to be actively involved in the regulation of T-
lymphocyte morphology and motility (Woodside et al., 2003). The Rho GTPases are 
molecular switches and are pivotal regulators of antigen-specific T-cell activation by 
antigen-presenting cells and immunological synapse formation (Deckert et al., 2005). The 
findings by Mzali et al. (Mzali et al., 2005) also suggested that Rho GTPases play crucial 
roles in T-lymphocyte functions and proliferation. These proteins are usually involved in T-
cell activation or proliferation, except CyPB which belongs to a class of highly conserved 
proteins that accelerate the folding of proteins and being a cyclosporine A (CsA) binding 
protein (Schreiber, 1991). This protein is abundant in thymus cytoplasm and appears to be 
involved in the regulation of T-lymphocyte activation and proliferation (Harding et al., 
1986), and inhibits the early T-cell activation (Liu et al., 1991) and prevents graft rejection 
(Schreiber and Crabtree, 1992). Furthermore, Denys et al. (1998) reported that plasma CyPB 
may enhance the immunosuppressive activity of CsA through a cell-mediated incorporation 
of CyPB–complexed CsA with in peripheral blood lymphocytes, and thus contributes to the 
acceptance and the good maintenance of organ transplantation. It is very interesting to 
elucidate the association of HLA-DR with CyPB on transgenic pigs especially in 
xenotransplantation. 
By mixed lymphocyte culture, Tg and NTg pigs' lymphocytes (pLC, stimulator) were 
compared to stimulate activation of human lymphocytes (hLC; effectors) so that the survival 
of HLA-DR Tg pig endothelial cells (pETC) in contact with xenografting lymphocytosis 
could be further evaluated. The hLC from HLA-DR15+ or HLA-DR15- healthy adults with O- 
or B-type man or women, and from HLA-DR15+ Tg and NTg pLC were harvested from 
peripheral blood samples by Ficoll-Paque™ Plus and separated from hematopoietic cells by 
culturing in 35 mm dish for overnight. Porcine LC was inactivated by 10.0 g/mL of 
mitomycin C for 30 min before mixed with hLC. These xeno-mixed LC reactions were 
cultivated in RPMI1640 medium adding 0, 0.1 and 1 g/mL of CsA and for 48 hours. The 
proliferation of hLC was evaluated by MTS assay. Results (Figure 3) thus obtained were: 
without CsA, the pLC stimulated 1.2 ±2.0 ~ 47.0 ±4.0% of hLC proliferation; while after 
addition of 0.1 and 1 g/mL CsA, the Tg vs. NTg pLC enhanced inhibition effects on hLC 
proliferation was 23.8 ±2.5 ~ 23.8 ±2.9% vs. 14.7 ±2.5 ~ 14.9 ±2.5%, and at 47.9 ±2.4 ~ 48.1 
±2.8% vs. 24.9 ±2.0 ~28.5 ±2.4%, respectively. Result showed that inactivation of hLC by CsA 
could be enhanced by HLA-DR transgenesis, suggesting that an ameliorated effect has 
occurred in acute xenograft rejection. The expression of CyPB in HLA-DR transgenic 
lymphocytes (intracellular) (Huang et al., 2006) could depress hLC activation. However, the 
improvement of survival rate of pETC (responder) varied highly in Tg pETC as compared to 
NTg pETC (data not shown). Although CyPB was expressed on endothelial cells 
(Carpentieret et al., 1999) and capable of enhancing T-cell adhesion to ETC extracellular 
matrix, then it could significantly attenuate by CsA (Allain et al., 2002). It is worth noting 
that HLA-DR transgenesis and the expression and secretion of CyPB on pETC will be firstly 
attached by activated hLC. 
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Fig. 3. Human lymphocytes mixed reaction with HLA-DR15+ transgenic (Tg) or non-Tg (NTg) 
lymphocytes. The surface antigens on human lymphocytes were with DR15+ or DR15-. There 
were 0, 0.1 and 1.0 g/mL immuosuppressor,  CsA, added into the medium of mixed 
lymphocytes culture tests to evaluate the synergic effects of transgenes. N= 3; * p＜0.05 and 
** p＜0.01. 
4. Long-term survival of HLA-DR pig skin in SCID mice after reconstitution 
with human PBMC and under short-term immunosuppression 
To test the role of donor-recipient HLA-II-match in xenotransplantation, the HLA-DR15+ 
porcine skins were transplanted to SCID mice which were thereafter reconstituted with 
HLA-DR 15+ or DR15- hPBMC. The studies were conducted under no 
immunosuppression (no CsA was given to hPBMC-SCID mice), or under 
immunosuppression (CsA was given intra-peritoneally to hPBMC-SCID mice for 12 days) 
to reveal the effectiveness of the graft. 
In studies of HLA-DR15+ porcine skin grafts to hPBMC-SCID mice under no 
immunosuppression (Tu et al., 2008), human CD4+ and CD8+ cells were detected from days 
7 to 29 after hPBMC reconstitution in hPBMC-SCID mice. Both CD4+ and CD8+ cells of 
HLA-DR15- hPBMC-SCID mice were significantly higher at day 29 post-grafting, compared 
with that of HLA-DR15+ hPBMC-SCID mice. In HLA-DR15+ hPBMC-SCID mice, the HLA-
DR15+ Tg pig skin grafts survived and integrated into mice, and illustrated 
histopathologically less cellular rejections which showed intact dermis with little 
lymphocytic infiltration. However, in HLA-DR15- hPBMC-SCID mice, the HLA-DR15+ 
transgenic pig skin grafts illustrated more cellular rejections which showed disrupted 
collagen, as well as mild to moderate lymphocytic infiltration. The results suggested that 
HLA-DR matching attenuated xenogenic cellular rejection. 
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In studies of HLA-DR15+ porcine skin grafts to hPBMC-SCID mice under 
immunosuppression with CsA (Tai et al., 2008), human CD4+ and CD8+ cells were found in 
hPBMC-SCID mice after reconstitution. Tests of MLC showed more responses of HLA-
DR15- hPBMC against HLA-DR15+ porcine PBMC. HLA-DR15+ porcine skin grafts survived 
more than 100 days in hPBMC-SCID mice which were reconstituted twice with HLA-DR15+ 
or HLA-DR15- hPBMC. In the negative control group, HLA-DR15+ porcine skins were 
rejected in all non-SCID (Balb/c) mice (data not shown), and the gross pictures showed 
disappeared porcine skin and growth of murine hair in non-SCID (Balb/c) mice. 
Histological pictures of transplanted HLA-DR15+ porcine skin grafts showed survived 
porcine epithelium in remodeling murine dermis (with organized collagen), and little 
lymphocytes infiltration in murine dermis.  
 
 
Fig. 4. Histological pictures (H&E staining) of transplanted HLA-DR15+ pig skin showed 
survived porcine epithelium in remodeling murine dermis (with organized collagen), and 
little lymphocytes infiltration in murine dermis. (DR+: reconstitution with HLA-DR 15+ 
hPBMC; DR-: reconstitution with HLA-DR 15- hPBMC.) 
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Although the results do not suggest that HLA-DR matching attenuated xenogenic cellular 
rejection, it showed that HLA-DR15+ pig skin grafts could survive over a prolonged period 
in hPBMC-SCID under a short period of immunosuppression with CsA. The long-term 
survival of HLA-DR15+ pig skin grafts in either HLA-DR15+ or HLA-DR15- hPBMC-SCID 
mice might be due to poor engraftment or function of reconstituted T cells, under 
immunosuppression with CsA. Because of the gradually decreased number of reconstituted 
T cells and suppression effect of CsA, HLA-DR15+ pig skin grafts were not rejected and 
therefore survived more than 100 days. In studies of T cell proliferation responses to porcine 
aortic endothelial cells (PAEC) either in the presence or absence of CsA, both allogeneic and 
xenogeneic T cell responses could be inhibited by in vitro (Fig. 3) or by therapeutic levels of 
CsA in vivo (Batten et al., 1999). 
In the studies of Hagihara et al. (1996), in vitro MLC and in vivo skin grafting were 
conducted by using HLA-DP Tg  mice (B6-DP mice). Xenogenic iso-(B6-DP to B6 mice) MLC 
showed positive but much less  responses when compared to allo-MLC responses. 
Nevertheless, B6-DP skin grafts were rejected in a similar time period as allo-skin grafts. 
Further studies of in vitro cytotoxic lymphocyte responses and delayed-type 
hypersensitivity reactions indicated that xenogeneic HLA-DP antigens could act as 
significant transplantation antigens equivalent to alloantigens despite their less stimulative 
activity in vitro. Results also support the interpretation that DP antigens act like a minor 
histocompatibility antigen beyond the difference of species (Hagihara et al., 1996). In our 
studies, xenogenic HLA-DR15+ antigens which act as minor histocompatibility antigens and 
swine leukocyte antigens (SLA) contributed simultaneously to exert acute cellular rejection 
of porcine skins in hPBMC-SCID mice.  
During allogenic skin rejection, the destruction of critical dermal structures that 
determine the ultimate viability of the skin graft is highly antigen-specific and is almost 
certainly accomplished by cytotoxic T cells. Whereas  destruction of non-critical epidermal 
structures of the skin allograft is antigen-nonspecific and can be accomplished by 
inflammatory cells or their secreted products. The MHC antigens are specific antigens for 
skin rejection. Matched MHC antigens of donors and recipients may improve survivals of 
allogenic skin graft. The in vivo skin-grafting in HLA-DR15+ hPBMC-SCID mice, matched 
HLA-DR15+ transgenic pig skin grafts displayed less cellular rejections. 
5. Summary and conclusion 
Our results from studies on the HLA-DPw0401 and HLA-DQw0601 Tg pig support the 
concept that increasing the similarity of MHC class II determinants between pig and 
human using an HLA-II Tg pig could reduce the xenogenic cellular response and 
attenuate human lymphocytic proliferation in xeno-mixed lymphocyte cultures and 
human-to-pig xenogenic cellular responses. In addition, proteomic approaches revealed 
that the HLA-DR15+ transgenic pigs could express more proteins including 
triosephosphate isomerase, cyclophilin B (CyPB), proteaseme and RhoA than their non-
transgenic littermates. These proteins are involved in T-cell activation or proliferation, 
except CyPB which belongs to a class of highly conserved proteins that accelerate the 
folding of proteins and being a cyclosporine A (CsA) binding protein. This protein is 
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abundant in thymus cytoplasm and appears to engage in the regulation of T-lymphocyte 
activation and proliferation, and inhibits the early T-cell activation and prevents graft 
rejection. Furthermore, the plasma CyPB may enhance the immunosuppressive activity of 
CsA through a cell-mediated incorporation of CyPB–complexed CsA within peripheral 
blood lymphocytes, and thus contributes to the acceptance and the good maintenance of 
organ transplanted. By using in vitro mixed xeno-lymphocytes culture, the inactivation of 
hLC by CsA could be enhanced by HLA-DR transgenesis, suggesting that an ameliorated 
effect has occurred in acute xenograft rejection. Further studies using in vivo skin-grafting 
in HLA-DR15+ hPBMC-SCID mice, HLA-DR15+ Tg pig skin grafts displayed less cellular 
rejections due to additional histocompatibility factor, HLA-DR15+, especially at the 
administration of CsA. 
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Accompanied by the advent of animal cloning, the technique of nuclear transfer produced alpha1,3-
galactosyltransferase-knockout (Gal-KO) pigs in many institutes, including the ones in Japan, at the beginning
of 21st Century. In addition, the controversy of the risks of PERV has gradually minimized, because of the fact
that there are no cases of PERV infections reported in humans. Furthermore, a large clinical wave for islet
allotransplantation resumed the interest of xenotransplantation, especially porcine islet transplantation and
some exceptions. Clinical trials were done in many countries so far, such as Sweden, China, Mexico, USA
(Inventory of Human Xenotransplantation Practices - IXA and HUG in collaboration with WHO). In addition, a
new clinical trial was approved by the government, and resumed the porcine islet transplantation research in
New Zealand two years ago.
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